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Received July 13, 2010; accepted March 17, 2011AbstractBackground: To evaluate the metabolic outcomes of the Diabetes Shared Care Program (DSCP) for Type 2 diabetes after completion of 1 year
and 3 years of intervention.
Methods: Total 162 Type 2 diabetes (average age 67.14 years with 62.35% men and 37.65% women) in 2004 were referred to the diabetes
educator for DSCP. Parameters related to diabetes among these patients were inquired, and biochemical data were compared before and after the
DSCP by using SPSS 12.0 software.
Results: These patients had 3.1% emergency utilization rate and 1.9% hospitalization utilization rate; significant improvement in diastolic blood
pressure (DBP), body weight after one year; and significant improvement in systolic blood pressure, DBP, body weight, total cholesterol, high-
density lipoproteins cholesterol (HDL-C) and low-density lipoproteins cholesterol (LDL-C) levels after three years. But only 4.84% and 8.87%
met all the A1C, blood pressure, and LDL-C target values after the 1- and 3-year interventions, respectively.
Conclusion: The A1C, blood pressure, and LDL-C achievement rate of DSCP in our hospital is low. DSCP is suggestive to patients with lower
duration of diabetes, high baseline A1C, systolic blood pressure, DBP, LDL-C, and low baseline high-density lipoproteins cholesterol levels.
Furthermore public health efforts are needed to control risk factors for vascular disease among diabetes.
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Diabetes is a metabolic disease that is diagnosed on the
basis of sustained hyperglycemia. People with Type 2 diabetes
are at elevated risk for a number of serious health problems,hinese Medical Association. All rights reserved.
Table 1
Characteristics of the patients at baseline (total 162 patients)
Variable Total
(n ¼ 162)
Withdrawal from
3-year DSCP
pa
Yes
(n ¼ 38)
No
(n ¼ 124)
Sex Female 61 (37.7%) 17 (44.7%) 44 (35.5%) 0.303
Male 101 (62.3%) 21 (55.3%) 80 (64.5%)
Age 50 yr 17 (10.5%) 6 (15.8%) 11 (8.9%) 0.355
51e60 yr 29 (17.9%) 4 (10.5%) 25 (20.2%)
61e70 yr 33 (20.4%) 9 (23.7%) 24 (19.4%)
71e80 yr 72 (44.4%) 15 (39.5%) 57 (46.0%)
>80 yr 11 (6.8%) 4 (10.5%) 7 (5.7%)
Duration of
diabetes
<1 yr 22 (13.6%) 2 (5.3%) 20 (16.1%) 0.480
1e5 yr 50 (30.9%) 10 (26.3%) 40 (32.3%)
6e10 yr 36 (22.2%) 10 (26.3%) 26 (21.0%)
11e15 yr 32 (19.8%) 9 (23.7%) 23 (18.5%)
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kidney failure, amputations, fractures, frailty, depression, and
cognitive decline.1 Diabetes and its associated complications
are known to place a tremendous burden on society and on the
cost of health care.2,3 Glycemic control is an important predictor
of many chronic complications of diabetes and its improvement
has been found to lead to cost savings.4e6 The findings of the
Diabetes Control and Complications Trial and the U.K.
Prospective Diabetes Study support the idea that rigorous gly-
cemic control not only improves a patient’s overall health but
also can prevent further complications.7,8 The education of
diabetic individuals on how to manage their own situation has
been considered important since the 1930s.9 The American
Diabetes Association (ADA) recommends the assessment of
self-management skills and the encouragement of continuous
education on diabetes. However, in this regard, 50e80% of
patients with diabetes have been found to have deficits in
knowledge and skill.10 Recently, Caliskan et al.11 reported that
only about 30% of people are aware that they suffer from dia-
betes, several studies have found that education about the self-
management of diabetes played a crucial role in improving
the metabolic outcome of diabetic patients,12e14 though there
were also some conflicting results.15e17 A number of factors,
including intervention characteristics, factors unique to the
patient, and the care system structure, might explain the
heterogeneity of the previous studies.18
Diabetes has become one of the major chronic diseases in
Taiwan. Long-term control of diabetes largely depends on
comprehensive education program and regular screening of
diabetes-related complications to achieve optimal control
goals. Our study aims to evaluate the metabolic outcomes of
Diabetes Shared Care Program (DSCP) for southern Taiwan
Type 2 diabetic patients after completion of 1 year and 3 years
of intervention.
2. Methods16e20 yr 13 (8.0%) 4 (10.5%) 9 (7.3%)
>20 yr 9 (5.6%) 3 (7.9%) 6 (4.8%)2.1. PopulationSMBG No 143 (88.3%) 33 (86.8%) 110 (88.7%) 0.754
Yes 19 (11.7%) 5 (13.2%) 14 (11.3%)
Family
history
No 86 (53.1%) 15 (39.5%) 71 (57.3%) 0.092
Yes 49 (30.2%) 13 (34.2%) 36 (29.0%)
Unknown 27 (16.7%) 10 (26.3%) 17 (13.7%)
Smoking No 133 (82.1%) 34 (89.5%) 99 (79.8%) 0.175
Yes 29 (17.9%) 4 (10.5%) 25 (20.2%)
Drinking No 134 (82.7%) 32 (84.2%) 102 (82.3%) 0.781
Yes 28 (17.3%) 6 (15.8%) 22 (17.7%)
Exercise No 45 (27.8%) 12 (31.6%) 33 (26.6%) 0.550
Yes 117 (72.2%) 26 (68.4%) 91 (73.4%)
BMI <24 60 (37.0%) 16 (42.1%) 44 (35.5%) 0.332
24e27 58 (35.8%) 13 (34.2%) 45 (36.3%)
27e30 26 (16.0%) 3 (7.9%) 23 (18.5%)
30 18 (11.1%) 6 (15.8%) 12 (9.7%)
Total 162 (100%) 38 (100%) 124 (100%)
a Use Chi-square test.
BMI ¼ body mass index; DSCP ¼ Diabetes Shared Care Program;
SMBG ¼ self-monitoring of blood glucose.Our study included 162 diabetic patients who were enrolled
in a DSCP from January 2004 to December 2004 and who
subsequently completed a 1-year and 3-year follow-up program
(124 diabetic patients finally) in the department of endocri-
nology and metabolism at Yongkang Veterans Hospital, Tainan,
Taiwan. The study was approved by the appropriate ethical
committees related to the institution in which it was performed.
Subjects were not enrolled until they were informed of what
was involved in the study and program and gave their written
consent. Those who met the following criteria were included in
the study if: (1) they had been diagnosed with Type 2 diabetes
(ICD-9 number 250.0e250.93) and their conditions had been
stabilized for more than a year following regular 3-month
visits to the outpatient endocrinology departmentand (2)
they had received basic information about diabetes and its care
during every such visit. A patient was excluded from our study
if: (1) the patient had one or more severe life-threatening
illnesses in addition to diabetes or (2) if he or she had everparticipated in the same kind of education program on diabetes
during the 1 year leading up to the study. At the beginning of
our study, we collected baseline data, shown in the third
column of Table 1. Among 162 patients, there were 69.28%
with hypertension, 48.14% with dyslipidemia, 33.33% with
retinopathy, 27.16% with obesity, 21.60% with nephropathy,
16.05% with coronary artery disease (CAD), 16.05% with
neuropathy, and 3.09% with cerebral vascular accident. There
were 38 patients that withdrew from the 3-year follow-up
program (124 diabetic patients finally). There was no
evidence to show that the withdrawal patients were associated
with more significant socio-demographic characteristics than
were with the non-withdrawal patients (Table 1). Only the
high-density lipoproteins cholesterol (HDL-C) level after
1-year intervention of withdrawal patients was significantly
higher than that of the other patients for clinical parameters of
the study group.
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Comparisonsa of clinical parameters between before and after 3-year DSCP
(total 124 patients)The program required physicians, diabetes specialist
nurses, and dietitians to work together to provide integrated
patient care. The physicians prescribed their medications
based on clinical practice recommendations made by the
ADA. All classes of antidiabetic, antihypertensive, and anti-
dyslipidemic drugs were added based on individualized care
plans, comorbidities, and other patient factors.
Furthermore to regular medical treatment, all participants
were introduced to self-care, nutrition, and other health issues
by certified diabetes specialist nurses and dietitians at the
beginning of the program. An individual 1-hour education
class using an interactive approach aiming to resolve the
problems of self-care, reinforce diabetic knowledge, and share
experiences was provided in the first week. The class was
delivered in Mandarin or other Chinese dialects. At the
beginning of the class, patients were asked to discuss their
understanding of diabetes. The class covered the main topics
of diabetes mellitus, causes, natural course and complications
of diabetes, mechanism of oral antidiabetes agents and insulin,
subcutaneous insulin injection technique, foot care, symptoms
of hypoglycemia and hyperglycemia, sick day management of
diabetes mellitus and targets for diabetic control, and so forth.
Individualized nutrition plans were prescribed, based on
recommendations made by the ADA, and those patients who
were overweight or obese were asked to reduce weight.
Furthermore, patients were encouraged to monitor their blood
glucose at home if possible. Patients’ status was routinely
monitored by taking the fasting blood sugar (FPG), A1C and
other biophysical measurements, including systolic blood
pressure (SBP), diastolic blood pressure (DBP), and body
weight (BW). Based on these measurements physicians,
nurses, and dietitians would reinforce the aims of the educa-
tion program every 3 months. After the 1-year and 3-year
programs, serum total cholesterol, triglyceride (TG), HDL-C,
low-density lipoproteins cholesterol (LDL-C), glutamic pyr-
uvic transaminase (GPT), and creatinine (Cr) levels were also
assessed.Items 3-year DSCP differenceb ( p)
2.3. Statistical analysisSBP (mmHg) 4.73 (0.006**)
DBP (mmHg) 3.70 (<0.001***)
BW (kg) 0.73 (0.027*)
FPG (mg/dL) 8.65 (0.166)
A1C (%) 0.05 (0.567)
Cholesterol (mg/dL) 7.61 (0.009*)
HDL-C (mg/dL) 3.17 (<0.001***)
LDL-C (mg/dL) 8.18 (0.001**)
TG (mg/dL) 1.94 (0.234)
GPT (U/L) 0.10 (0.058)
Cr (mg/dL) 0.20 (<0.001***)
a Use Wilcoxon sign rank test.
b Difference is the mean difference of clinical parameter before minus after.
BW ¼ body weight; Cr ¼ creatinine; DBP ¼ diastolic blood pressure;
DSCP ¼ Diabetes Shared Care Program; FPG ¼ fasting blood sugar;
GPT ¼ glutamic pyruvic transaminase; HDL-C ¼ high-density lipoproteins
cholesterol; LDL-C ¼ low-density lipoproteins cholesterol; SBP ¼ systolic
blood pressure; TG ¼ triglyceride.
* A p value <0.05; **p < 0.01; ***p < 0.001.A computer system was used to integrate patients’ baseline
data and subsequent data. All the data for this study were
obtained from this system. All private information was removed
during the analysis. Changes in SBP, DBP, BW, FPG, A1C,
cholesterol, HDL-C, LDL-C, TG, GPT, and Cr levels after the
1-year and 3-year programs were analyzed by Wilcoxon sign
rank test. To identify patients who might be more responsive to
the program, we compared the improvement in A1C values
after the 1-year intervention. We also analyzed the effectiveness
between the subgroups of different A1C baseline before and
after 1-year intervention (total 162 patients). Improvement in
each one of these was analyzed using the Wilcoxon sign rank
test. Multiple linear regressions by stepwise method were also
conducted to analyze the chief metabolic outcome, ABC (A
indicates A1C; B, blood pressure (BP); C, LDL-C) after 1-yearDSCP. Statistical analyses were performed by using SPSS 12.0
version statistics software. A p value <0.05 (two tailed) was
considered statistically significant.3. Results3.1. DSCP has positive effects on SBP, DBP, BW,
cholesterol, LDL-C and HDL-C levelsThe effects of DSCP on each clinical parameter can be seen
in Table 2, which illustrates mean difference and p value of
statistical test after 3-year intervention. The numerical data with
mean difference (denoted by d) and p value (denoted by p)
before and after 3-year intervention (total 124 patients) were:
SBP (135.38  17.67 mmHg vs. 130.65  12.65 mmHg, d ¼
4.73, p ¼ 0.006); DBP (76.96  10.32 mmHg vs.
73.26  6.69 mmHg, d ¼ 3.70, p < 0.001); BW (66.01 
10.00 kg vs. 65.28  9.87 kg, d ¼ 0.73, p ¼ 0.027); FPG
(169.86  58.98 mg/dL vs. 161.21  56.49 mg/dL, d ¼ 8.65,
p ¼ 0.166); A1C (8.24  1.74% vs. 8.18  1.80%, d ¼ 0.05,
p ¼ 0.567); total serum cholesterol (190.34  37.97 mg/dL vs.
182.73  37.61 mg/dL, d ¼ 7.61, p ¼ 0.009); HDL-C
(44.38  13.37 mg/dL vs. 47.55  12.68 mg/dL, d ¼ 3.17,
p < 0.001); LDL-C (116.40  29.72 mg/dL vs. 108.23 
34.05 mg/dL, d¼ 8.18, p¼ 0.001); TG (145.32 84.48 mg/dL
vs. 143.39  96.45 mg/dL, d ¼ 1.94, p ¼ 0.234); GPT
(42.51  35.39 U/L vs. 42.61  40.14 U/L, d ¼ 0.10,
p ¼ 0.058); and Cr (0.97  0.36 mg/dL vs. 1.17  0.61 mg/dL,
d ¼ 0.20, p < 0.001).
The results demonstrated that DBP, BW, and HDL-C levels
were significantly lower after 1-year DSCP intervention.
Moreover, SBP, DBP, BW, total serum cholesterol, and LDL-C
levels were significantly lower and HDL-C levels were
significantly higher after 3-year DSCP intervention.
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different A1C level patientsWe further analyzed the effectiveness on clinical parame-
ters between before and after 1-year DSCP (total 162 patients)
for different A1C baseline groups. As shown in Table 3, the
group with baseline A1C  9% demonstrated significant
improvement ( p < 0.05) on DBP, FPG, and A1C levels after
1-year DSCP intervention.3.3. The effects of DSCP on A1C, BP, and LDL-C levels
of diabetes patientsAmong these patients, there were baseline 25.8% with A1C
<7%, 41.9% with BP <130/80 mmHg, and 31.5% with LDL-
C <100 mg/dL. We analyzed whether DSCP could increase
patients’ number/percentage to achieve the A1C, BP, and
LDL-C target levels. As shown in Fig. 1, the percentages of
A1C <7% increased from 25.8% to 30.6% and 32.3% after
1-year and 3-year intervention, respectively. The percentages
of BP <130/80 mmHg increased from 41.9% to 57.3% and
58.1% after 1-year and 3-year intervention, respectively.
Furthermore, the percentages of LDL-C <100 mg/dL
increased from 31.5% to 33.1% and 42.7% after 1-year and
3-year intervention, respectively. Moreover, total ABC target
achievement rates increased from 4.03% to 4.84% and 8.87%
after 1-year and 3-year intervention, respectively.
We found that there were only five of 162 patients who ever
visited the emergency room because of diabetic complication
after 1-year intervention. Furthermore, there were only three
of 162 patients who ever were hospitalized because of diabetic
complication after 1-year intervention. The emergency and
hospitalization utilization rates were 3.1% and 1.9%,Table 3
Comparisonsa of clinical parameters differenceb among the subgroups of
different A1C baseline after 1-year DSCP (total 162 patients)
Items A1C < 7%
(n ¼ 39)
A1C 7e7.9%
(n ¼ 36)
A1C 8e8.9%
(n ¼ 33)
A1C  9%
(n ¼ 54)
SBP (mmHg) 4.92 2.83 0.64 0.93
DBP (mmHg) 6.15** 3.11 0.30 5.04**
BW (kg) 0.57 0.71 1.32** 0.024
FPG (mg/dL) 11.95** 1.50 28.15** 58.65***
A1C (%) 0.47*** 0.069 0.21 1.39***
Cholesterol
(mg/dL)
2.23 0.39 8.97 5.33
HDL-C (mg/dL) 2.28 1.64 2.15 2.63
LDL-C (mg/dL) 2.31 1.89 5.73 2.39
TG (mg/dL) 12.95 33.50* 11.97 11.59
GPT (U/L) 3.44 0.08 4.03 5.89
Cr (mg/dL) 0.00 0.06* 0.009 0.004
a Use Wilcoxon sign rank test.
b Difference is the mean difference of clinical parameter before 1-year
DSCP minus after 1-year DSCP.
BW ¼ body weight; Cr ¼ creatinine; DBP ¼ diastolic blood pressure;
DSCP ¼ Diabetes Shared Care Program; FPG ¼ fasting blood sugar;
GPT ¼ glutamic pyruvic transaminase; HDL-C ¼ high-density lipoproteins
cholesterol; LDL-C ¼ low-density lipoproteins cholesterol; SBP ¼ systolic
blood pressure; TG ¼ triglyceride.
* A p-value <0.05; **p < 0.01; ***p < 0.001.respectively. To further determine the relationship between the
chief metabolic outcome, ABC, after 1-year DSCP and base-
line clinical parameters, multiple linear regression analysis
was used (total 162 patients). Results (Table 4) revealed that
the three factors which contributed most in improvement of
A1C were higher A1C status, lower total cholesterol level, and
lower DM duration at baseline; the factor which contributed
most in improvement of SBP status was higher SBP at base-
line; the two factors contributing most in improvement of DBP
status were higher DBP and higher age at baseline; and the
two factors contributing most in improvement of LDL-C status
were higher LDL-C and lower HDL-C levels at baseline.
4. Discussion
Diabetes is a chronic and progressively deteriorative
disease. In prospective epidemiologic studies, the incidence of
many of these outcomes is directly associated with the degree
of hyperglycemia, as measured by the plasma glucose or A1C
level (the measurement of mean blood glucose level for 2e3
months). The U.K. Prospective Diabetes Study has revealed
that each percentage point reduction in the A1C level is
associated with a 37% reduction in microvascular complica-
tion, a 14% reduction in myocardial infarction, a 12%
reduction in stroke, and a 16% reduction in heart failure.19
Few studies have been done regarding the effect of a self-
management education program on A1C control in diabetic
patients. In fact, those studies have inconsistent results.
Gagliardino and Etchegoyen demonstrated an improvement in
the A1C level after a 1-year teaching program (9.0  2.0% vs.
7.8  1.6%, p < 0.001).20 However, Gabbay et al. found no
difference in the A1C levels after a 1-year intervention
(7.46  1.4% vs. 7.45  1.4%, p > 0.05).21 Our results
demonstrated that diabetes education insignificantly improves
the FPG and A1C levels after 1-year intervention, and this
improvement effect decreases after 3-year intervention. There
may be two explanations for these differences. First, in
previous studies, the average baseline A1C level was at least
9%,14,20 whereas in our study, the baseline A1C level was
8.28  1.75%. Second, as time went by, adherence to the
program and motivation decreased. Other studies have repor-
ted similar findings.18 Another study reported that the positive
effect on glycemic control and behavior as a consequence of
self-management training was more obvious in the short-term
follow-up.12 A Bulgarian study illustrated no difference in
glycemic control between men and women.14 The gender
difference was not obvious in our study either.
Elevated SBP or DBP and left ventricular hypertrophy are
clearly associated with an increased risk of CAD.22 Better BP
control can help to limit complications because of microvas-
cular, macrovascular, and stroke in diabetic patients.19 Studies
have shown that a 2-mmHg reduction in DBP would result in
a 17% decrease in the prevalence of hypertension, and a 6%
reduction in the risk of coronary heart disease, and a 15%
reduction in risk of stroke and transient ischemic attack.23 In
the PEDNID-LA study,20 the inclusion criteria did not confine
stable BP before entry. Furthermore, high baseline BP
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Fig. 1. ABC target achievement rate of VHYK (124 patients) after 1-year and 3-year Diabetes Shared Care Program (ABC ¼ A1C, blood pressure, LDL-C;
BP ¼ blood pressure; LDL-C ¼ low-density lipoproteins cholesterol; VHYK ¼ Yongkang Veterans Hospital).
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adding antihypertensive drugs might affect estimations of the
effect of education on disease status. Gabbay et al. reported that
self-care management could improve BP control after 1-year
intervention.21 Although their baseline BP (SBP ¼ 137 
19 mmHg, DBP¼ 7710 mmHg) was not as high as that in the
PEDNID-LA study, they also acknowledged that the observed
effects might be related to a higher number of antihypertensive
medications. In our study, we found significant improvement in
DBP (76.28  10.65 vs. 72.36  9.52 mmHg, d ¼ 3.91,
p < 0.001) after 1-year intervention and significant improve-
ment in SBP (135.38  17.67 vs. 130.65  12.65 mmHg,Table 4
Multiple linear regression analysis of the metabolic outcome, ABC, after
1-year DSCP (total 162 patients)
Independent variable Dependent variable
A1C SBP DBP LDL-C
Constant 2.252*** 63.414*** 65.934*** 8.333
Baseline SBP 0.481***
Baseline DBP 0.730***
Baseline A1C 0.597***
Baseline cholesterol 0.01**
Baseline LDL-C 0.212**
Baseline HDL-C 0.348*
Age 0.175**
Duration of DM 0.047**
R2 0.347 0.249 0.473 0.076
p-value <0.001 <0.001 <0.001 0.002
ABC ¼ A1C, blood pressure, LDL-C; DSCP ¼ Diabetes Shared Care
Program; DBP ¼ diastolic blood pressure; HDL-C ¼ high-density lipoproteins
cholesterol; LDL-C ¼ low-density lipoproteins cholesterol; SBP ¼ systolic
blood pressure.
*A p value <0.05; **p < 0.01; ***p < 0.001.d ¼ 4.73, p < 0.005) and DBP (76.96  10.32 vs. 73.26 
6.69 mmHg, d ¼ 3.70, p < 0.001) after 3-year intervention.
The observed effects might be related to the antihypertensive
drugs and lifestyle behavior education.
HDL-C has emerged as an important independent predictor
of CAD. In our study, we found DSCP had a significant
positive influence on the lipid profile especially the total
cholesterol, LDL-C, and HDL-C levels after 3-year interven-
tion. Although we did not find significant improvement in the
LDL-C and TG levels after 1-year intervention, the trend of
improvement in the HDL-C and LDL-C levels was obvious
after 3-year intervention. Glycemic control, obesity, the diet
pattern, renal disease, hepatic disease, drugs, alcohol, exercise,
and smoking are associated with TG level. It is more difficult
to reveal the significant differences, because basal TG levels
(148.49  101.27 mg/dL) were fairly well in control. Further-
more, there was a wide standard deviation in TG level. A
significant improvement might only be observed over the long-
term.18 All patients with low HDL and/or high TG should
receive recommendations for lifestylemodifications that include
low saturated fat diet and increased physical activity. Lipid-
lowering drugs were prescribed if lifestyle modifications failed.
Non-compliance with instructions for taking medications
and non-adherence to suggestion about lifestyle changes has
been shown to counter any positive pharmacological effects.
Such problems can be addressed by a comprehensive diabetic
program.18 The dietitian plays a pivotal role in counseling
patients on diet modification and in designing a diet for patients
based on their preferences and health status. Diabetes specialist
nurses regularly reinforce compliance and the concept of
a healthy life. The adherence to exercise recommendations is
also deemed crucial. To evaluate the change of lifestyle, we
checked the diet records and exercise performance records at
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to supervise the patients, participate in the discussion groups,
and provide information about compliance. De Bont et al.16
reported that their diabetic education program led to an
improvement in the BW; this was not surprising as the partic-
ipants were obese and were only followed up for 6 months. In
our program, we also found significant improvement in BW
after 1 year and 3 years of intervention (0.58 kg and 0.73 kg,
respectively). The observed effects were mainly because of the
diet modification and exercise education. The importance of
controlling glycemic levels is well known in clinical practice.
Survey data from the National Diabetes Health Promotion
Center in Taiwan 24 indicated that only 32.4% of adults with
diagnosed diabetes achieved an A1C of <7%, only 30.9% had
a BP <130/80 mmHg, and just 35.3% had a total cholesterol
<160 mg/dL or LDL-C<100 mg/dL. Most distressing was that
only 4.1% of people with diabetes achieved all the 3 treatment
goals.24 Diabetic individuals with diagnosis of Type 1 diabetes,
lesser body mass index and those not using insulin were more
likely to attain all ABC goals.24 Our program showed only
8.87% of 124 patients met all three, ABC, of the control targets
after 3-year intervention. However, in the US,25 the prevalence
of diagnosed diabetes was 6.5% from 1999 to 2002 and 7.8%
from 2003 to 2006 and increased significantly in women, non-
Hispanic whites, and obese people. Although there were no
significant changes in the pattern of antidiabetic treatment, the
age-adjusted percentages of people with diagnosed diabetes
achieving glycemic and LDL targets increased from 43.1% to
57.1% and from 36.1% to 46.5%, respectively. A1C decreased
from 7.62% to 7.15% during this period. The age-adjusted
percentage achieving all three targets increased insignificantly
from 7.0% to 12.2%. There is an escalating demand for health
professionals and medication to treat diabetes in the general
population.25
Our study has some limitations. Although we could clearly
evaluate the effect of our DSCP on biophysical parameters, it
was difficult to assess and quantify its effect on the realization
and behavior change. Another limitation was that there was no
randomized control group with which to compare the differ-
ence. Furthermore, although we excluded subjects involved in
the same program previously, we could not totally obviate the
effect of mass media or messages provided by other health
organizations. Variations in the improvement of examination
results may have also been affected by other causes, such as
the medication dosage to control the hyperglycemia, hyper-
tension and dyslipidemia, change of medication, cooperation
of patients, efforts of physicians, or pre-existing health
conditions of patients. We cannot judge the impacts of medi-
cation on goal attainment in the study. It is worth, using
a longitudinal approach, to evaluate the long-term effect of
different care models. Moreover, it may be interesting to
perform studies similar to ours in different regions of Taiwan
to scrutinize the impact of geographic variables. It is difficult
to assess the contribution of each component; however, it is
clear that optimal diabetes management requires an organized,
systematic approach and involvement of a coordinated team of
health care professionals.26In conclusion, this was a study without controls, and the
sample size was too small to draw conclusions about the
promotion of the system to every patient diagnosed with Type
2 diabetes. Although our results failed to compare the effec-
tiveness of the DSCP for the patients in the system and
patients who did not enter into the shared care system, it
showed 4.84% and 8.87% of diabetic patients met all the ABC
target values after the 1- and 3-year interventions, respectively,
through education program. The DSCP is suggestive to
patients with lower DM duration, high baseline A1C, SBP,
DBP, LDL-C, and low baseline HDL-C levels. Furthermore
public health efforts are needed to control risk factors for
vascular disease among diabetes.
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